The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Research Report 2025

Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 2002983

No of Pages : 106

Synopsis
The global market for Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment was valued at US$ 2150 million in the year 2024 and is projected to reach a revised size of US$ 3095 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Sexually transmitted disease nucleic acid amplification testing equipment is a type of molecular diagnostic instrument specifically used to detect the nucleic acid of sexually transmitted disease (STDs) pathogens. It achieves high sensitivity and specificity diagnosis of STDs pathogens by amplifying and detecting specific nucleic acid sequences. This type of device is based on nucleic acid amplification technology and can directly detect trace amounts of pathogen genetic material from clinical samples, becoming one of the gold standards for modern STDs diagnosis. From the perspective of technical principles, the core technologies mainly used by the equipment include polymerase chain reaction (PCR) technology, isothermal amplification technology, and transcription mediated amplification technology. From the perspective of device types, it can be divided into two categories: fully automatic systems and semi-automatic systems. The fully automated system integrates sample processing, nucleic acid extraction, amplification, and detection, greatly reducing manual operation steps and cross contamination risks, making it suitable for high-throughput detection needs. Semi automatic systems require step-by-step operation, which is lower in cost but more complex to operate.
The global market for sexually transmitted disease nucleic acid amplification testing equipment has shown a growing trend in recent years. The increasing burden of sexually transmitted diseases constitutes a fundamental driving force for market growth, and policy and regulatory support is another key driving factor. Technological progress and innovation continue to drive market development. Breakthroughs in the field of molecular biology have continuously improved the sensitivity, automation, and detection capabilities of nucleic acid amplification detection equipment. The reform of the healthcare system and the increase in awareness of testing have also promoted market expansion. Medical institutions are transitioning from disease treatment to health management, emphasizing early screening and prevention of sexually transmitted diseases. The strategic layout of multinational corporations such as Abbott Laboratories and Roche Diagnostics is mainly characterized by technology leadership and global operations, and their testing equipment has high market recognition. Chinese domestic enterprises such as BGI Genomics and Rendu Biotechnology focus more on cost-effectiveness and localized services in their competitive strategies. The market entry point for emerging enterprises is usually technological innovation or specific application scenarios. Reducing costs and improving accessibility remain the core challenges facing the industry. The industry needs to break through these limitations through technological and business model innovation. Talent cultivation and capacity building are crucial for market expansion, and equipment manufacturers should strengthen cooperation with educational institutions and industry associations to develop standardized training courses and certification systems. Sexually transmitted disease testing involves highly sensitive personal information, and with the popularization of digital testing and remote services, data security and privacy protection are facing greater challenges. Cross disciplinary cooperation and ecological construction are the key to future competition. Manufacturers need to collaborate with IT companies to develop intelligent diagnostic systems, collaborate with logistics companies to optimize sample transportation networks, and collaborate with medical institutions to design more efficient testing processes. The main directions for future technological innovation and product evolution are full automation and intelligence, miniaturization and portable devices, multiple detection and composite analysis, breakthroughs in detection speed, and non-invasive detection.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment.
The Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BD
BioMerieux
Cepheid
Roche
Hologic
DiaSorin
Abbott Laboratories
Thermo Fisher Scientific
Siemens Healthineers
BGI Genomics
Shanghai Rendu Biotechnology
Shanghai Hongshi Medical Technology
Tianlong
Liferiver Biotech
Sansure Biotech
Bioperfectus Technologies
Macro Micro-Test
Zhongke Shengyi Technology
Hybribio
Segment by Type
Fully Automatic Equipment
Semi-Automatic Equipment
Segment by Application
Clinical Diagnosis
Public Health Surveillance
Research And Development
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Index
1 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Overview
1.1 Product Definition
1.2 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment by Type
1.2.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Fully Automatic Equipment
1.2.3 Semi-Automatic Equipment
1.3 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment by Application
1.3.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Value by Application (2024 VS 2031)
1.3.2 Clinical Diagnosis
1.3.3 Public Health Surveillance
1.3.4 Research And Development
1.3.5 Others
1.4 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size Estimates and Forecasts
1.4.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue 2020-2031
1.4.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales 2020-2031
1.4.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Competition by Manufacturers
2.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Product Type & Application
2.7 Global Key Manufacturers of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Date of Enter into This Industry
2.8 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Competitive Situation and Trends
2.8.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Players Market Share by Revenue
2.8.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Scenario by Region
3.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region: 2020-2031
3.2.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region: 2020-2025
3.2.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region: 2026-2031
3.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region: 2020-2031
3.3.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region: 2020-2025
3.3.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region: 2026-2031
3.4 North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Facts & Figures by Country
3.4.1 North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2031)
3.4.3 North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Facts & Figures by Country
3.5.1 Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2031)
3.5.3 Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Facts & Figures by Region
3.6.1 Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region (2020-2031)
3.6.3 Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Facts & Figures by Country
3.7.1 Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2031)
3.7.3 Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Type (2020-2031)
4.1.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Type (2020-2025)
4.1.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Type (2026-2031)
4.1.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Type (2020-2031)
4.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Type (2020-2031)
4.2.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Type (2020-2025)
4.2.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Type (2026-2031)
4.2.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Type (2020-2031)
4.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Application (2020-2031)
5.1.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Application (2020-2025)
5.1.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Application (2026-2031)
5.1.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Application (2020-2031)
5.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Application (2020-2031)
5.2.1 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Application (2020-2025)
5.2.2 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Application (2026-2031)
5.2.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Application (2020-2031)
5.3 Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 BioMerieux
6.2.1 BioMerieux Company Information
6.2.2 BioMerieux Description and Business Overview
6.2.3 BioMerieux Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioMerieux Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.2.5 BioMerieux Recent Developments/Updates
6.3 Cepheid
6.3.1 Cepheid Company Information
6.3.2 Cepheid Description and Business Overview
6.3.3 Cepheid Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cepheid Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.3.5 Cepheid Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Hologic
6.5.1 Hologic Company Information
6.5.2 Hologic Description and Business Overview
6.5.3 Hologic Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hologic Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.5.5 Hologic Recent Developments/Updates
6.6 DiaSorin
6.6.1 DiaSorin Company Information
6.6.2 DiaSorin Description and Business Overview
6.6.3 DiaSorin Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 DiaSorin Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.6.5 DiaSorin Recent Developments/Updates
6.7 Abbott Laboratories
6.7.1 Abbott Laboratories Company Information
6.7.2 Abbott Laboratories Description and Business Overview
6.7.3 Abbott Laboratories Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Laboratories Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Company Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Thermo Fisher Scientific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Siemens Healthineers
6.9.1 Siemens Healthineers Company Information
6.9.2 Siemens Healthineers Description and Business Overview
6.9.3 Siemens Healthineers Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Siemens Healthineers Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.9.5 Siemens Healthineers Recent Developments/Updates
6.10 BGI Genomics
6.10.1 BGI Genomics Company Information
6.10.2 BGI Genomics Description and Business Overview
6.10.3 BGI Genomics Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BGI Genomics Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.10.5 BGI Genomics Recent Developments/Updates
6.11 Shanghai Rendu Biotechnology
6.11.1 Shanghai Rendu Biotechnology Company Information
6.11.2 Shanghai Rendu Biotechnology Description and Business Overview
6.11.3 Shanghai Rendu Biotechnology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Rendu Biotechnology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.11.5 Shanghai Rendu Biotechnology Recent Developments/Updates
6.12 Shanghai Hongshi Medical Technology
6.12.1 Shanghai Hongshi Medical Technology Company Information
6.12.2 Shanghai Hongshi Medical Technology Description and Business Overview
6.12.3 Shanghai Hongshi Medical Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Hongshi Medical Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.12.5 Shanghai Hongshi Medical Technology Recent Developments/Updates
6.13 Tianlong
6.13.1 Tianlong Company Information
6.13.2 Tianlong Description and Business Overview
6.13.3 Tianlong Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Tianlong Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.13.5 Tianlong Recent Developments/Updates
6.14 Liferiver Biotech
6.14.1 Liferiver Biotech Company Information
6.14.2 Liferiver Biotech Description and Business Overview
6.14.3 Liferiver Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Liferiver Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.14.5 Liferiver Biotech Recent Developments/Updates
6.15 Sansure Biotech
6.15.1 Sansure Biotech Company Information
6.15.2 Sansure Biotech Description and Business Overview
6.15.3 Sansure Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Sansure Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.15.5 Sansure Biotech Recent Developments/Updates
6.16 Bioperfectus Technologies
6.16.1 Bioperfectus Technologies Company Information
6.16.2 Bioperfectus Technologies Description and Business Overview
6.16.3 Bioperfectus Technologies Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bioperfectus Technologies Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.16.5 Bioperfectus Technologies Recent Developments/Updates
6.17 Macro Micro-Test
6.17.1 Macro Micro-Test Company Information
6.17.2 Macro Micro-Test Description and Business Overview
6.17.3 Macro Micro-Test Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Macro Micro-Test Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.17.5 Macro Micro-Test Recent Developments/Updates
6.18 Zhongke Shengyi Technology
6.18.1 Zhongke Shengyi Technology Company Information
6.18.2 Zhongke Shengyi Technology Description and Business Overview
6.18.3 Zhongke Shengyi Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Zhongke Shengyi Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.18.5 Zhongke Shengyi Technology Recent Developments/Updates
6.19 Hybribio
6.19.1 Hybribio Company Information
6.19.2 Hybribio Description and Business Overview
6.19.3 Hybribio Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Hybribio Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product Portfolio
6.19.5 Hybribio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Industry Chain Analysis
7.2 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Production Mode & Process Analysis
7.4 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales and Marketing
7.4.1 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Channels
7.4.2 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Distributors
7.5 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Customer Analysis
8 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Dynamics
8.1 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Industry Trends
8.2 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Drivers
8.3 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Challenges
8.4 Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Product Type & Application
Table 12. Global Key Manufacturers of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region (2020-2025) & (Units)
Table 18. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Region (2020-2025)
Table 19. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region (2026-2031) & (Units)
Table 20. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Region (2026-2031)
Table 21. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Region (2020-2025)
Table 23. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Region (2026-2031)
Table 25. North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2025) & (Units)
Table 27. North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2026-2031) & (Units)
Table 28. North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2025) & (Units)
Table 32. Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2026-2031) & (Units)
Table 33. Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2025) & (Units)
Table 42. Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2026-2031) & (Units)
Table 43. Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units) by Type (2020-2025)
Table 51. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units) by Type (2026-2031)
Table 52. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Type (2020-2025)
Table 53. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Type (2026-2031)
Table 54. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Type (2020-2025)
Table 57. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Type (2026-2031)
Table 58. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units) by Application (2020-2025)
Table 61. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units) by Application (2026-2031)
Table 62. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Application (2020-2025)
Table 63. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Application (2026-2031)
Table 64. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Application (2020-2025)
Table 67. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Application (2026-2031)
Table 68. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price (US$/Unit) by Application (2026-2031)
Table 70. BD Company Information
Table 71. BD Description and Business Overview
Table 72. BD Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. BD Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 74. BD Recent Developments/Updates
Table 75. BioMerieux Company Information
Table 76. BioMerieux Description and Business Overview
Table 77. BioMerieux Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BioMerieux Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 79. BioMerieux Recent Developments/Updates
Table 80. Cepheid Company Information
Table 81. Cepheid Description and Business Overview
Table 82. Cepheid Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Cepheid Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 84. Cepheid Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Roche Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 89. Roche Recent Developments/Updates
Table 90. Hologic Company Information
Table 91. Hologic Description and Business Overview
Table 92. Hologic Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Hologic Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 94. Hologic Recent Developments/Updates
Table 95. DiaSorin Company Information
Table 96. DiaSorin Description and Business Overview
Table 97. DiaSorin Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. DiaSorin Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 99. DiaSorin Recent Developments/Updates
Table 100. Abbott Laboratories Company Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Laboratories Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. Thermo Fisher Scientific Company Information
Table 106. Thermo Fisher Scientific Description and Business Overview
Table 107. Thermo Fisher Scientific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Thermo Fisher Scientific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 109. Thermo Fisher Scientific Recent Developments/Updates
Table 110. Siemens Healthineers Company Information
Table 111. Siemens Healthineers Description and Business Overview
Table 112. Siemens Healthineers Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Siemens Healthineers Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 114. Siemens Healthineers Recent Developments/Updates
Table 115. BGI Genomics Company Information
Table 116. BGI Genomics Description and Business Overview
Table 117. BGI Genomics Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. BGI Genomics Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 119. BGI Genomics Recent Developments/Updates
Table 120. Shanghai Rendu Biotechnology Company Information
Table 121. Shanghai Rendu Biotechnology Description and Business Overview
Table 122. Shanghai Rendu Biotechnology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Shanghai Rendu Biotechnology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 124. Shanghai Rendu Biotechnology Recent Developments/Updates
Table 125. Shanghai Hongshi Medical Technology Company Information
Table 126. Shanghai Hongshi Medical Technology Description and Business Overview
Table 127. Shanghai Hongshi Medical Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Shanghai Hongshi Medical Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 129. Shanghai Hongshi Medical Technology Recent Developments/Updates
Table 130. Tianlong Company Information
Table 131. Tianlong Description and Business Overview
Table 132. Tianlong Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Tianlong Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 134. Tianlong Recent Developments/Updates
Table 135. Liferiver Biotech Company Information
Table 136. Liferiver Biotech Description and Business Overview
Table 137. Liferiver Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Liferiver Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 139. Liferiver Biotech Recent Developments/Updates
Table 140. Sansure Biotech Company Information
Table 141. Sansure Biotech Description and Business Overview
Table 142. Sansure Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Sansure Biotech Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 144. Sansure Biotech Recent Developments/Updates
Table 145. Bioperfectus Technologies Company Information
Table 146. Bioperfectus Technologies Description and Business Overview
Table 147. Bioperfectus Technologies Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Bioperfectus Technologies Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 149. Bioperfectus Technologies Recent Developments/Updates
Table 150. Macro Micro-Test Company Information
Table 151. Macro Micro-Test Description and Business Overview
Table 152. Macro Micro-Test Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Macro Micro-Test Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 154. Macro Micro-Test Recent Developments/Updates
Table 155. Zhongke Shengyi Technology Company Information
Table 156. Zhongke Shengyi Technology Description and Business Overview
Table 157. Zhongke Shengyi Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Zhongke Shengyi Technology Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 159. Zhongke Shengyi Technology Recent Developments/Updates
Table 160. Hybribio Company Information
Table 161. Hybribio Description and Business Overview
Table 162. Hybribio Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Hybribio Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Product
Table 164. Hybribio Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Distributors List
Table 168. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Customers List
Table 169. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Trends
Table 170. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Drivers
Table 171. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Challenges
Table 172. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report


List of Figures
Figure 1. Product Picture of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment
Figure 2. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Share by Type: 2024 & 2031
Figure 4. Fully Automatic Equipment Product Picture
Figure 5. Semi-Automatic Equipment Product Picture
Figure 6. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Share by Application: 2024 & 2031
Figure 8. Clinical Diagnosis
Figure 9. Public Health Surveillance
Figure 10. Research And Development
Figure 11. Others
Figure 12. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size (2020-2031) & (US$ Million)
Figure 14. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales (2020-2031) & (Units)
Figure 15. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Average Price (US$/Unit) & (2020-2031)
Figure 16. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Report Years Considered
Figure 17. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Share by Manufacturers in 2024
Figure 18. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Players: Market Share by Revenue in Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment in 2024
Figure 20. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Country (2020-2031)
Figure 23. North America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Country (2020-2031)
Figure 24. United States Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Country (2020-2031)
Figure 27. Europe Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Country (2020-2031)
Figure 28. Germany Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Region (2020-2031)
Figure 35. China Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Country (2020-2031)
Figure 43. Latin America Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment by Type (2020-2031)
Figure 54. Global Revenue Market Share of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment by Type (2020-2031)
Figure 55. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment by Application (2020-2031)
Figure 57. Global Revenue Market Share of Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment by Application (2020-2031)
Figure 58. Global Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Price (US$/Unit) by Application (2020-2031)
Figure 59. Sexually Transmitted Disease Nucleic Acid Amplification Testing Equipment Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’